Tandem Diabetes Care : Management Change/Compensation - Form 8-K
November 13, 2023 at 06:06 am EST
Share
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 7, 2023, Tandem Diabetes Care, Inc. ("Tandem" or the "Company") and David B. Berger, the Company's Executive Vice President and Chief Operating Officer, determined that he will be stepping down from his current position effective December 31, 2023. Mr. Berger is responsible for the Company's clinical, quality and regulatory functions, having served in a variety of leadership roles throughout his tenure at Tandem, including the historical oversight of legal, customer technical support and operations. Tandem anticipates that Mr. Berger will provide transition advisory services to the Company through 2024, and the Company will make a subsequent filing to disclose the terms of any related agreement.
Tandem Diabetes Care Inc. published this content on 13 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 November 2023 11:05:15 UTC.
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.